Alex Jones FDA Coronavirus

NBC News/YouTube

FDA tells Alex Jones he can’t market his products as coronavirus cures

The letter outlined several products that were misleading.

 

Andrew Wyrich

Tech

Published Apr 10, 2020   Updated Apr 10, 2020, 11:39 am CDT

The U.S. Food and Drug Administration (FDA) told InfoWars founder Alex Jones that he needs to stop marketing products he’s selling on his online store as cures and treatments for the coronavirus.

Featured Video Hide

The FDA sent a letter to Jones on Thursday after determining a number of products InfoWars was selling were being marketed as ways to “mitigate, prevent, treat, diagnose, or cure COVID-19 in people.”

Advertisement Hide

Jones profits off the sale of an assortment of pills, gear, survivalist rations and other products sold on his online store.

The products flagged by the FDA included “Superblue Silver Immune Gargle,” “SuperSilver Whitening Toothpaste,” “SuperSilver Wound Dressing Gel,” and “Superblue Fluoride Free Toothpaste.”

The letter explains that Jones marketed the products during videos in February and March, including one where he asks people to buy the product “if you are concerned about the coronavirus or the flu or the common cold.”

The FDA gave Jones 48 hours to respond to their letter with “specific steps you have taken to correct” the violations of marketing the products. If he doesn’t, he could face “legal action, including, without limitation, seizure, and injunction.”

“We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that you are not misleadingly representing your products as safe and effective for a COVID-19 related use for which they have not been approved by FDA and that you do not make claims that misbrand the products,” the letter reads.

Advertisement Hide

Last month, the New York Attorney General’s office issued a cease-and-desist to Jones over claims that toothpaste and pills he was selling could fight coronavirus.

READ MORE:

Share this article
*First Published: Apr 10, 2020, 11:32 am CDT